STATE OF WISCONSIN INVESTMENT BOARD
Position in TRVI — Trevi Therapeutics, Inc.
CIK 854157
MADISON, WI
Position in TRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,607,340
+$97,854 QoQ
Shares Held
134,731
+11.7% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE OF WISCONSIN INVESTMENT BOARD holds $473,893,217 across 164 Biotechnology names. TRVI ranks #67 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
136,548 | $60,974,143 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
55,274 | $42,706,903 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
68,883 | $22,791,318 | |
| 4 | INSM |
INSMED Inc
|
114,346 | $18,697,857 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
254,483 | $14,798,186 | |
| 6 | MRNA |
Moderna, Inc.
|
227,162 | $11,539,829 | |
| 7 | INCY |
Incyte Corp
|
116,878 | $11,000,557 | |
| 8 | TECH |
BIO-TECHNE Corp
|
208,871 | $10,915,598 |
All Filings in TRVI
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,607,340 | 134,731 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,509,486 | 120,566 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,127,975 | 123,276 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $641,330 | 117,245 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,101,662 | 175,145 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $265,740 | 64,500 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||